Bond Euro Investment Bank 0.375% ( US298785JK32 ) in USD

Euro Investment Bank

100 % ▲

Luxembourg

US298785JK32 ( in USD )

0.375% per year ( payment 2 times a year)

26/03/2026

Prospectus brochure of the bond European Investment Bank (EIB) US298785JK32 en USD 0.375%, maturity 26/03/2026

1 000 USD

5 000 000 000 USD

298785JK3

26/09/2025 ( In 140 days )

The European Investment Bank (EIB) is the European Union's long-term lending institution, financing projects that contribute to EU policy objectives.

The Bond issued by Euro Investment Bank ( Luxembourg ) , in USD, with the ISIN code US298785JK32, pays a coupon of 0.375% per year.
The coupons are paid 2 times per year and the Bond maturity is 26/03/2026

Filed pursuant to Rule 424(b)(5)
Registration No. 333-251291
PROSPECTUS SUPPLEMENT
(To Prospectus dated December 23, 2020)

European Investment Bank
$5,000,000,000 0.375% Notes due 2026
_______________________
The 0.375% notes due 2026 offered hereby (the "Notes") will bear interest at a rate of 0.375% per year. The European
Investment Bank (the "EIB") will pay interest on the Notes on March 26 and September 26 of each year, commencing on
March 26, 2021 (short first coupon for the period from, and including, January 12, 2021 to, but excluding, March 26, 2021).
The Notes will mature on March 26, 2026. The EIB will not have the right to redeem the Notes before their scheduled
maturity. The Notes will be unconditional, direct and general obligations of the EIB in accordance with the terms for their
payment and performance. The Notes will rank pari passu with any present or future indebtedness of the EIB represented
by any unsubordinated and unsecured notes or bonds.
Application has been made for the Notes to be listed on the Official List of the Luxembourg Stock Exchange and admitted
to trading on the Bourse de Luxembourg, which is the regulated market of the Luxembourg Stock Exchange. No assurance
can be given that such application will be approved or that any of the Notes will be listed and admitted to trading thereon,
and settlement of the Notes is not conditioned on obtaining this listing.
_______________________
PRICE OF THE NOTES 99.364%
_______________________

Per Note
Total
Public offering price (1) .........................................................................................
99.364%
$ 4,968,200,000
Underwriting discount ..........................................................................................
0.125%
$
6,250,000
Proceeds, before expenses, to the EIB (1) .............................................................
99.239% $ 4,961,950,000

(1) Plus accrued interest, if any, from January 12, 2021 if settlement occurs after that date.
_______________________
Neither the Securities and Exchange Commission nor any state securities commission has approved or
disapproved of the Notes or determined if this prospectus supplement or the accompanying prospectus is truthful or
complete. Any representation to the contrary is a criminal offense.
_______________________
The underwriters named in this prospectus supplement expect to deliver the Notes to purchasers in book-entry form only,
through the facilities of The Depository Trust Company ("DTC") for the accounts of its direct and indirect participants
(including Euroclear Bank SA/NV ("Euroclear") and Clearstream Banking S.A. ("Clearstream")) on or about January 12, 2021.
_______________________

CITIGROUP
DEUTSCHE BANK TD SECURITIES

_______________________
The date of this prospectus supplement is January 5, 2021.

TABLE OF CONTENTS
Prospectus Supplement

Prospectus

Page

Page
About this Prospectus Supplement ......S-3
About this Prospectus ......................... 3
Where You Can Find More
Where You Can Find More
Information ..........................................S-4
Information ......................................... 4
Incorporation by Reference ..................S-5
Incorporation by Reference ................. 4
Forward-Looking Statements ...............S-8
Forward-Looking Statements .............. 7
Summary of the Offering .....................S-9
The European Investment Bank .......... 8
Use of Proceeds ....................................S-11
Use of Proceeds ................................... 13
Description of Notes ............................S-12
Description of Securities ..................... 14
Underwriters ........................................S-16
Book-Entry, Delivery and Form ......... 21
Validity of the Notes ............................S-23
Plan of Distribution ............................. 26
Experts .................................................S-23
Currency Conversions and Foreign
General Information .............................S-24
Exchange Risks ................................... 27
Official Statement ................................S-24
Taxation .............................................. 29

Validity of the Securities .................... 36
Experts ................................................ 36

Enforceability of Civil Liabilities ....... 37

Authorized Representative in the
United States ....................................... 38

Official
Statement
...............................

38

S-2

ABOUT THIS PROSPECTUS SUPPLEMENT
This document consists of two parts. The first part is this prospectus supplement, which
describes the specific terms of this offering and the Notes being offered. This prospectus
supplement may also add, update or change information contained in the accompanying
prospectus. The second part, the accompanying prospectus, presents general information about
us and a general description of the debt securities we may offer from time to time, some of which
does not apply to the Notes being offered. If the information in this prospectus supplement
differs from the information contained in the accompanying prospectus, you should rely on the
information in this prospectus supplement. If we use a capitalized term in this prospectus
supplement and do not define the term in this document, it is defined in the accompanying
prospectus.
You should read both this prospectus supplement and the accompanying prospectus together
with additional information described under the headings "Where You Can Find More
Information" and "Incorporation by Reference" below before you purchase the Notes. We have
not authorized anyone to provide you with information different from that contained or
incorporated by reference in this prospectus supplement and the accompanying prospectus or any
"free writing prospectus" prepared by or on behalf of us. We take no responsibility for, and can
provide no assurance as to the reliability of, any other information that others may give you.
You should not assume that the information in this prospectus supplement, the accompanying
prospectus or any document incorporated by reference therein is accurate or complete at any date
other than the date indicated on the cover page of those documents. Our business, financial
condition, results of operations and prospects may have changed since those dates.
We are not offering to sell the Notes or soliciting offers to purchase the Notes in any
jurisdiction where the offer or sale is not permitted. The Notes are offered globally for sale in
those jurisdictions in the United States, Canada, Europe, Asia and elsewhere where it is lawful
to make such offers. The distribution of this prospectus supplement and the accompanying
prospectus and the offering of the Notes in certain jurisdictions may be restricted by law. Persons
into whose possession this prospectus supplement and the accompanying prospectus come
should inform themselves about and observe any such restrictions. This prospectus supplement
and the accompanying prospectus do not constitute, and may not be used in connection with, an
offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not
authorized or in which the person making such offer or solicitation is not qualified to do so or to
any person to whom it is unlawful to make such offer or solicitation. See "Underwriters--Selling
Restrictions".
While application has been made for the Notes to be listed on the Official List of the
Luxembourg Stock Exchange and admitted to trading on the Bourse de Luxembourg, which is
the regulated market of the Luxembourg Stock Exchange, we cannot guarantee that such
application will be approved or that any of the Notes will be listed and admitted to trading
thereon, and settlement of the Notes is not conditioned on obtaining this listing. See "Description
of Notes--Listing".
S-3

References in this prospectus supplement to "we", "our" or "us" are to the EIB. References
to "U.S. dollars", "USD", "U.S. $", "dollar" or "$" are to the lawful currency of the United
States.

WHERE YOU CAN FIND MORE INFORMATION
The registration statement of which this prospectus supplement and the accompanying
prospectus form part, including the attached exhibits and schedules, contains additional relevant
information about the Notes. The rules and regulations of the SEC allow us to omit certain
information included in the registration statement from this prospectus supplement and the
accompanying prospectus.
While the EIB is not subject to the periodic reporting requirements of the U.S. Securities
Exchange Act of 1934, as amended (the "Exchange Act"), we file reports and other information
with the SEC under the Exchange Act on a voluntary basis. The SEC maintains an internet site
that contains reports, proxy and information statements, and other information regarding issuers
that file electronically with the SEC (http://www.sec.gov), on which all our filings made after
December 15, 2002 are available.
This prospectus supplement and the accompanying prospectus will be published on the
official website of the Luxembourg Stock Exchange (http://www.bourse.lu). Information
available on this website is not, and shall not be deemed to be, part of or incorporated by reference
into this prospectus supplement.

S-4

INCORPORATION BY REFERENCE
The SEC allows us to "incorporate by reference" into this prospectus supplement and the
accompanying prospectus the information we file with the SEC, which means that:
· we can disclose important information to you by referring you to another document
filed separately with the SEC;
· information in a document incorporated by reference in this prospectus supplement
is considered to be a part of this prospectus supplement and the accompanying
prospectus;
· information in this prospectus supplement automatically updates and supersedes
information in earlier documents that are incorporated by reference in this prospectus
supplement and the accompanying prospectus;
· information in a document incorporated by reference in this prospectus supplement
automatically updates and supersedes information in earlier documents that are
incorporated by reference in this prospectus supplement and the accompanying
prospectus; and
· information that we file in the future with the SEC that we incorporate by reference
in this prospectus supplement will automatically update and supersede information in
this prospectus supplement and the accompanying prospectus.
This prospectus supplement incorporates by reference the documents listed below that the
EIB previously filed with the SEC. They contain important information about us. All other
documents which the EIB previously filed with the SEC, including those listed under the heading
"Incorporation by Reference" in the accompanying prospectus, have been superseded by the
documents listed below.

SEC Filings

Annual Reports on
· For the fiscal year ended December 31, 2019, as filed with the SEC
Form 18-K .................
on May 5, 2020 (File No. 001-05001)
· For the fiscal year ended December 31, 2018, as filed with the SEC
on May 3, 2019 (File No. 001-05001)
Amendments on
· Amendment No. 1 to the Annual Report on Form 18-K/A for the
Form 18-K/A .............
fiscal year ended December 31, 2019, as filed with the SEC on

May 19, 2020 (File No. 001-05001)
· Amendment No. 2 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
June 9, 2020 (File No. 001-05001)
S-5

· Amendment No. 4 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
August 10, 2020 (File No. 001-05001)
· Amendment No. 5 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
August 10, 2020 (File No. 001-05001)
· Amendment No. 6 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
September 16, 2020 (File No. 001-05001)
· Amendment No. 7 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
September 23, 2020 (File No. 001-05001)
· Amendment No. 8 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
October 21, 2020 (File No. 001-05001)
· Amendment No. 9 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
November 6, 2020 (File No. 001-05001)
· Amendment No. 10 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
December 11, 2020 (File No. 001-05001)
· Amendment No. 11 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2019, as filed with the SEC on
December 23, 2020 (File No. 001-05001)
· Amendment No. 1 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
May 16, 2019 (File No. 001-05001)
· Amendment No. 3 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
August 6, 2019 (File No. 001-05001)
· Amendment No. 4 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
August 27, 2019 (File No. 001-05001)
· Amendment No. 5 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
September 5, 2019 (File No. 001-05001)
· Amendment No. 6 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
October 9, 2019 (File No. 001-05001)
· Amendment No. 7 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
January 14, 2020 (File No. 001-05001)
S-6

· Amendment No. 8 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
February 3, 2020 (File No. 001-05001)
· Amendment No. 9 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
February 11, 2020 (File No. 001-05001)
· Amendment No. 10 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
March 2, 2020 (File No. 001-05001)
· Amendment No. 12 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
April 15, 2020 (File No. 001-05001)
· Amendment No. 13 to the Annual Report on Form 18-K/A for the
fiscal year ended December 31, 2018, as filed with the SEC on
April 23, 2020 (File No. 001-05001)

The EIB also incorporates by reference in this prospectus supplement any future filings, or
portions of such filings, made with the SEC under the Exchange Act, after the date of this
prospectus supplement until completion of this offering, to the extent such filings, or such
portions of such filings, indicate that they are intended to be incorporated by reference in this
prospectus supplement.
Upon written or oral request, we will provide to any person, including any beneficial owner,
to whom a copy of this prospectus supplement is delivered, at no cost to such person, a copy of
any or all of the information that has been incorporated by reference in this prospectus
supplement but not delivered with this prospectus supplement. You may make such a request by
writing or telephoning us at the following address or telephone number:

European Investment Bank
Capital Markets Department
98-100, boulevard Konrad Adenauer
L-2950 Luxembourg
Grand Duchy of Luxembourg
Telephone: (+352) 43 79 1
E-mail: [email protected]

S-7

FORWARD-LOOKING STATEMENTS
This prospectus supplement and the accompanying prospectus and documents incorporated
by reference in this prospectus supplement and the accompanying prospectus may contain
forward-looking statements. Statements that are not historical facts, including statements about
our beliefs and expectations, are forward-looking statements.
Forward-looking statements involve inherent risks, uncertainties and other factors that may
cause our actual results, performance or achievements to differ materially from the anticipated
results, performance or achievements expressed or implied in these forward-looking statements.
Although we believe that the expectations reflected in such forward-looking statements and
forecasts are reasonable, no assurance can be given that such expectations will prove to have
been correct. Accordingly, actual results could differ materially from those contained in any
forward-looking statements. Consequently, you are cautioned not to place undue reliance on
forward-looking statements.
Forward-looking statements speak only as of the date they are made, and we undertake no
obligation to update publicly or release any revisions to these forward-looking statements in light
of new information or to reflect events or circumstances after the date of the particular statement
or to reflect the occurrence of unanticipated events, except to the extent required by applicable
law. All subsequent forward-looking statements attributable to us or any person acting on our
behalf are qualified by the cautionary statements herein.
S-8

SUMMARY OF THE OFFERING
The following summary is qualified in its entirety by, and should be read in conjunction with,
the more detailed information appearing elsewhere in this prospectus supplement and the
accompanying prospectus.
Issuer ........................................ European Investment Bank.
Securities Offered .................... $5,000,000,000 aggregate principal amount of 0.375% Notes
due 2026.
Ranking .................................... The Notes will be unconditional, direct and general
obligations of the EIB in accordance with the terms for their
payment and performance. The Notes will rank pari passu
with any present or future indebtedness of the EIB
represented by any unsubordinated and unsecured notes or
bonds.
Maturity Date .......................... March 26, 2026.
Interest Payment Dates ........... March 26 and September 26 of each year, commencing on
March 26, 2021 (short first coupon for the period from, and
including, January 12, 2021 to, but excluding, March 26,
2021).
Record Dates ............................ The close of business on March 16 and September 16
(whether or not a business day) prior to each Interest Payment
Date.
Interest Rate ............................ 0.375% per annum.
Denominations ......................... The Notes will be issued in minimum denominations of
$1,000 and integral multiples thereof.
Redemption .............................. The Notes are not subject to redemption prior to their
scheduled maturity.
Use of Proceeds ........................ The net proceeds from the sale of the Notes will be used in
the general operations of the EIB, including disbursements of
loans heretofore or hereafter granted by the EIB. See "Use
of Proceeds".
Further Issues .......................... The EIB may from time to time, without notice to or the
consent of any of the holders of the Notes, create and issue
additional notes ranking pari passu with the Notes and
having the same terms as to status, interest rate, maturity,
redemption or otherwise in all respects as the Notes (except
for the public offering price, the issue date, and in some
cases, the first interest payment date). Such additional notes
S-9

shall be consolidated and form a single series with the Notes,
including for purposes of voting and redemptions, and
increase the aggregate principal amount of the Notes. See
"Description of Notes--Further Issues".
Governing Law ........................ State of New York.
Markets .................................... The Notes are offered for sale in those jurisdictions in the
United States, Canada, Europe, Asia and elsewhere where it
is lawful to make such offers. See "Underwriters--Selling
Restrictions".
Listing ....................................... Application has been made for the Notes to be listed on the
Official List of the Luxembourg Stock Exchange and
admitted to trading on the Bourse de Luxembourg, which is
the regulated market of the Luxembourg Stock Exchange.
No assurance can be given that such application will be
approved or that any of the Notes will be listed and admitted
to trading thereon, and settlement of the Notes is not
conditioned on obtaining this listing. If the application is
approved, the EIB will have no obligation to maintain such
listing, and may delist the Notes at any time.
Book-Entry Form, Settlement The Notes will be represented by the Global Note registered
and Clearance .......................... in the name of Cede & Co. as nominee for DTC. The Global
Note will be deposited with a custodian for DTC. Investors
may elect to hold interests in the Global Note through DTC,
if they are participants in DTC, or indirectly through
organizations that are participants in DTC. Initial settlement
for the Notes will be made in immediately available funds in
U.S. dollars. See "Book-Entry, Delivery and Form" in the
accompanying prospectus.
Closing and Delivery ............... It is currently expected that delivery of the Notes will occur
on or about January 12, 2021.
Withholding Tax ..................... The EIB has been advised that under current U.S. tax law
payments of principal of and interest on the Notes may
generally be made by the EIB without withholding or
deduction for U.S. withholding taxes. For further details, see
"Taxation" in the accompanying prospectus.
Fiscal Agent, Registrar,
Citibank, N.A., London Branch.
Transfer Agent and Paying
Agent .........................................
Listing Agent ........................... Banque Internationale à Luxembourg S.A.

S-10